ArborGen (RUBNF) Stock Price, News & Analysis

Company Overview

ArborGen is a forestry biotechnology company focused on developing and supplying genetically improved tree seedlings for commercial forestry and reforestation. Its work combines tree breeding, biotechnology and nursery production to improve characteristics such as growth, form, disease resistance and adaptability to local growing conditions.

The company has produced seedlings for several commercially important species, including loblolly pine, eucalyptus and radiata pine. Its products are intended for timber and fiber producers, forest owners and other customers involved in plantation forestry, with an emphasis on improving forest productivity and supporting renewable wood supplies.

ArborGen was established in 2000 through a collaboration involving Rubicon Limited, International Paper and MeadWestvaco. The company has served forestry markets in the United States and internationally, including Australia, New Zealand and Brazil. ArborGen has also been associated with research and development involving genetically modified trees, particularly eucalyptus, although the availability and regulatory status of specific products varies by market.

Key Stats

• Today's Range: $0.02 to $0.02
• 50-Day Range: $0.02 to $0.03
• 52-Week Range: $0.02 to $0.07
• Volume: N/A
• Average Volume: 3,943 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Materials
• Industry: Lumber & Wood Production
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RUBNF
• CIK: N/A
• Web: www.rubicon-nz.com
• Phone: (649) 356-9800
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A